Komori
Linical (2183) · RiskRestated

Competition for Talent, Including CRAs

First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2020.

4entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20202016: 120162017: 120172018: 120182019: 020192020: 12020
Same theme, other companies
Difficulty Securing, Developing and Retaining Specialized and Highly Skilled IT PersonnelA theme 539 companies write about · 554 as a headwind · 4 as a tailwind

The whole theme swung hardest in 2026: 34 of 108 companies on the "Worse" side.

102 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 558 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2020RestatedAnnual report

    「To address these risks, the Group is working to diversify its recruitment methods, including year-round and career-track hiring, while expanding personnel training and developing and strengthening internal systems to accommodate more diverse working arrangements.」

    Additional disclosure describes responses to the risks of recruitment competition, personnel shortages and personnel outflows through year-round hiring, career-track hiring, expanded training and more diverse working arrangements.
  2. FY2018RestatedAnnual report

    「To date, the Group has not faced any significant problems in recruiting personnel. However, intensified competition for talent among pharmaceutical companies, pharmacy chains, CROs and other industries could prevent the Group from hiring personnel as planned.」

    While stating that there are currently no significant problems, the risk of failing to meet hiring plans due to competition for CRAs and other personnel, personnel outflows and delays in training continues.
  3. FY2017RestatedAnnual report

    「To date, the Group has not faced any significant problems in recruiting personnel. However, intensified competition for talent among pharmaceutical companies, pharmacy chains, CROs and other industries could prevent the Group from hiring personnel as planned.」

    While stating that there are currently no significant problems, the disclosure continues to identify the risk of failing to meet hiring plans due to competition for CRAs and other personnel, delays in training and personnel outflows.
  4. FY2016First statedAnnual report

    「To date, the Group has not faced any significant problems in recruiting personnel. However, intensified competition for talent among pharmaceutical companies, pharmacy chains, CROs and other industries could prevent the Group from hiring personnel as planned.」

    While stating that there are currently no significant problems, the disclosure indicates that intensified recruitment competition and personnel outflows could prevent hiring from proceeding as planned.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Linical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Competition for Talent, Including CRAs | Linical Co.,Ltd. (2183) | Komori